Krsnaa Diagnostics Ltd
NSE:KRSNAA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Krsnaa Diagnostics Ltd
NSE:KRSNAA
|
IN |
|
R
|
Revenue Group Bhd
KLSE:REVENUE
|
MY |
Balance Sheet
Balance Sheet Decomposition
Krsnaa Diagnostics Ltd
Krsnaa Diagnostics Ltd
Balance Sheet
Krsnaa Diagnostics Ltd
| Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
1 116
|
1 273
|
1 529
|
2 419
|
1 088
|
535
|
38
|
|
| Cash |
1 030
|
1 189
|
1 282
|
1 534
|
861
|
512
|
38
|
|
| Cash Equivalents |
86
|
84
|
247
|
885
|
227
|
24
|
0
|
|
| Short-Term Investments |
19
|
46
|
71
|
24
|
861
|
1 728
|
646
|
|
| Total Receivables |
565
|
617
|
728
|
579
|
800
|
1 954
|
3 015
|
|
| Accounts Receivables |
562
|
614
|
725
|
579
|
780
|
1 879
|
2 814
|
|
| Other Receivables |
2
|
3
|
3
|
1
|
20
|
75
|
201
|
|
| Inventory |
42
|
51
|
72
|
92
|
286
|
436
|
327
|
|
| Other Current Assets |
144
|
150
|
81
|
228
|
55
|
70
|
119
|
|
| Total Current Assets |
1 886
|
2 136
|
2 481
|
3 342
|
2 229
|
4 212
|
4 145
|
|
| PP&E Net |
2 641
|
2 827
|
3 110
|
4 116
|
4 933
|
6 546
|
6 704
|
|
| PP&E Gross |
2 641
|
2 827
|
3 110
|
4 116
|
4 933
|
6 546
|
6 704
|
|
| Accumulated Depreciation |
406
|
318
|
661
|
1 034
|
1 531
|
2 230
|
2 962
|
|
| Intangible Assets |
8
|
15
|
12
|
23
|
28
|
24
|
29
|
|
| Note Receivable |
111
|
239
|
271
|
60
|
122
|
374
|
222
|
|
| Long-Term Investments |
149
|
63
|
27
|
1 158
|
1 556
|
151
|
1 292
|
|
| Other Long-Term Assets |
495
|
1 019
|
144
|
62
|
230
|
412
|
425
|
|
| Total Assets |
5 290
N/A
|
6 300
+19%
|
6 045
-4%
|
8 762
+45%
|
9 099
+4%
|
11 719
+29%
|
12 816
+9%
|
|
| Liabilities | ||||||||
| Accounts Payable |
417
|
381
|
786
|
773
|
621
|
823
|
971
|
|
| Accrued Liabilities |
12
|
15
|
23
|
23
|
129
|
173
|
163
|
|
| Short-Term Debt |
540
|
932
|
347
|
60
|
0
|
957
|
1 386
|
|
| Current Portion of Long-Term Debt |
258
|
196
|
351
|
19
|
82
|
222
|
178
|
|
| Other Current Liabilities |
506
|
284
|
331
|
613
|
160
|
639
|
356
|
|
| Total Current Liabilities |
1 733
|
1 808
|
1 838
|
1 488
|
992
|
2 815
|
3 054
|
|
| Long-Term Debt |
4 102
|
6 179
|
1 680
|
331
|
243
|
419
|
472
|
|
| Deferred Income Tax |
0
|
0
|
107
|
78
|
128
|
164
|
226
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
304
|
283
|
102
|
21
|
349
|
223
|
237
|
|
| Total Liabilities |
6 139
N/A
|
8 270
+35%
|
3 727
-55%
|
1 917
-49%
|
1 712
-11%
|
3 621
+112%
|
3 988
+10%
|
|
| Equity | ||||||||
| Common Stock |
52
|
52
|
65
|
157
|
157
|
161
|
161
|
|
| Retained Earnings |
0
|
0
|
0
|
0
|
842
|
1 321
|
2 069
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
6 380
|
6 608
|
6 597
|
|
| Other Equity |
901
|
2 021
|
2 254
|
6 687
|
9
|
7
|
0
|
|
| Total Equity |
849
N/A
|
1 970
-132%
|
2 319
N/A
|
6 844
+195%
|
7 387
+8%
|
8 098
+10%
|
8 828
+9%
|
|
| Total Liabilities & Equity |
5 290
N/A
|
6 300
+19%
|
6 045
-4%
|
8 762
+45%
|
9 099
+4%
|
11 719
+29%
|
12 816
+9%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
31
|
31
|
31
|
31
|
31
|
32
|
32
|
|